Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-16-018868
Filing Date
2016-11-22
Accepted
2016-11-22 15:35:00
Documents
1
Period of Report
2016-11-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4110116hexter_oramedpharma.html 4  
1 OWNERSHIP DOCUMENT f4110116hexter_oramedpharma.xml 4 3391
  Complete submission text file 0001213900-16-018868.txt   4993
Mailing Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390
Business Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390 011 972-2-566-0001
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9 ALFASI JERUSALEM L3 92302
Business Address
Hexter Joshua (Reporting) CIK: 0001573235 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 162013101